United Capital Management Of Ks, Inc. Abb Vie Inc. Transaction History

United Capital Management Of Ks, Inc.

$420 Million
Q2 2024

A detailed history of United Capital Management Of Ks, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, United Capital Management Of Ks, Inc. holds 28,512 shares of ABBV stock, worth $5.55 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

28,512

Previous 28,340 0.61%

Holding current value

$5.55 Million

Previous $5.16 Million 5.23%

% of portfolio

1.17%

Previous 1.25%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $26,623 - $31,090	172 Added 0.61%	28,512 $4.89 Million
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $136,326 - $155,331	-853 Reduced 2.92%	28,340 $5.16 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $138,563 - $156,054	1,007 Added 3.57%	29,193 $4.52 Million
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $7,347 - $8,505	55 Added 0.2%	28,186 $4.2 Million
Q2 2023 Aug 04, 2023	BUY	$132.51 - $164.9 $695,014 - $864,900	5,245 Added 22.92%	28,131 $3.79 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $140,416 - $161,710	971 Added 4.43%	22,886 $3.65 Million
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $66,527 - $79,783	481 Added 2.24%	21,915 $3.54 Million
Q3 2022 Oct 31, 2022	BUY	$134.21 - $153.93 $32,210 - $36,943	240 Added 1.13%	21,434 $2.88 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $775,488 - $985,899	-5,635 Reduced 21.0%	21,194 $3.25 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $52,528 - $65,172	-398 Reduced 1.46%	26,829 $4.35 Million
Q4 2021 Jan 18, 2022	BUY	$107.43 - $135.93 $71,440 - $90,393	665 Added 2.5%	27,227 $3.69 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $34,473 - $39,132	324 Added 1.23%	26,562 $2.87 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $103,105 - $114,865	980 Added 3.88%	26,238 $2.96 Million
Q1 2021 Apr 27, 2021	BUY	$102.3 - $112.62 $109,972 - $121,066	1,075 Added 4.45%	25,258 $2.7 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $120,091 - $162,135	1,492 Added 6.58%	24,183 $2.59 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $84,793 - $99,519	987 Added 4.55%	22,691 $1.99 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $209,838 - $280,794	2,860 Added 15.18%	21,704 $2.13 Million
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $94,041 - $142,577	1,458 Added 8.39%	18,844 $1.44 Million
Q4 2019 Jan 24, 2020	BUY	$72.13 - $90.25 $100,188 - $125,357	1,389 Added 8.68%	17,386 $1.54 Million
Q3 2019 Oct 15, 2019	BUY	$62.98 - $75.72 $71,986 - $86,547	1,143 Added 7.69%	15,997 $1.19 Million
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $23,520 - $30,064	358 Added 2.47%	14,854 $1.09 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $99,279 - $116,846	1,287 Added 9.74%	14,496 $1.14 Million
Q4 2018 Jan 10, 2019	BUY	$77.85 - $96.01 $84,778 - $104,554	1,089 Added 8.99%	13,209 $1.22 Million
Q3 2018 Oct 09, 2018	BUY	$88.91 - $98.84 $1.08 Million - $1.2 Million	12,120 New	12,120 $1.1 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.

Account

United Capital Management Of Ks, Inc. Abb Vie Inc. Transaction History